サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390612

免疫組織染色市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Immunohistochemistry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
免疫組織染色市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の免疫組織染色市場規模は2022年に24億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに38億米ドルに達し、2022年から2028年の間に7.96%の成長率（CAGR）を示すと予測しています。

免疫組織染色（IHC）は、抗体を用いて組織サンプル中の特定の抗原を確認する検査法です。抗体は一般に酵素や蛍光色素と結合し、研究者が顕微鏡下で抗原を確認するのに役立ちます。IHCはがんのような慢性疾患の診断に広く用いられ、その種類を区別するのに役立っています。限られた数のタンパク質、酵素、組織構造を同定する従来の酵素染色技術と比較して、IHCは特異的な抗原抗体反応を伴う。その結果、細胞内の特定の細胞成分の分布や局在を可視化するために、医学研究室や臨床診断において重要な技術として支持を集めています。

免疫組織染色の市場動向：

コロナウイルス病（COVID-19）の突然の発症は、世界のヘルスケア危機につながっています。このため、迅速で効果的な薬剤開発や感染診断のためにIHCの必要性が高まっています。これとは別に、がん、腫瘍、筋疾患、神経変性疾患を患う人の数が大幅に増加していることも、市場を牽引する重要な要因となっています。さらにIHCは、創傷治癒、免疫反応、組織拒絶反応、生体材料相互作用など、さまざまな生物学的プロセスや病態を特徴付けることができます。その結果、基本的な生物学的プロセスにおける特定の遺伝子産物の機能を決定したり、組織内の感染因子を確認したりするのに利用されるようになっています。さらに最近、いくつかの新しい蛍光色素、優れたカラーコントラスト、高解像度、同時多色イメージングが導入されました。これらの技術革新により、免疫蛍光顕微鏡は今後数年間で、細胞レベルでの病態生物学的プロセスを研究するための便利なツールになると予想されます。

本レポートで扱う主な質問

  • 世界の免疫組織染色市場はこれまでどのように推移してきたか？
  • COVID-19が世界の免疫組織染色市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • 用途別の市場内訳は？
  • 最終用途別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界の免疫組織染色市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 免疫組織染色の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 抗体
    • 市場動向
    • 主要セグメント
      • 一次抗体
      • 二次抗体
    • 市場予測
  • 装置
    • 市場動向
    • 主要セグメント
      • スライド染色システム
      • 組織マイクロアレイ
      • 組織処理システム
      • スライドスキャナー
      • その他
    • 市場予測
  • 試薬
    • 市場動向
    • 主要セグメント
      • 組織染色
      • ブロッキング血清と試薬
      • 発色基質
      • 固定試薬
      • 安定剤
      • 有機溶媒
      • タンパク質分解酵素
      • 希釈剤
    • 市場予測
  • キット
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 診断
    • 市場動向
    • 主要セグメント
      • がん
      • 感染症
      • 心血管疾患
      • 自己免疫疾患
      • 糖尿病
      • 腎臓疾患
    • 市場予測
  • 医薬品検査
    • 市場動向
    • 市場予測

第8章 市場内訳：最終用途別

  • 病院と診断研究所
    • 市場動向
    • 市場予測
  • 調査機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abcam plc
    • Agilent Technologies Inc.
    • Beckman Coulter Inc.（Danaher Corporation）
    • Becton Dickinson and Company
    • Bio SB Inc.
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Cell Signaling Technology Inc.
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Immunohistochemistry Market: Major Drivers and Challenges
  • Figure 2: Global: Immunohistochemistry Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Immunohistochemistry Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Immunohistochemistry Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Immunohistochemistry Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Immunohistochemistry Market: Breakup by End Use (in %), 2022
  • Figure 7: Global: Immunohistochemistry Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Immunohistochemistry (Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Immunohistochemistry (Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Immunohistochemistry (Equipment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Immunohistochemistry (Equipment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Immunohistochemistry (Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Immunohistochemistry (Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Immunohistochemistry (Kits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Immunohistochemistry (Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Immunohistochemistry (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Immunohistochemistry (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Immunohistochemistry (Drug Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Immunohistochemistry (Drug Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Immunohistochemistry (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Immunohistochemistry (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Immunohistochemistry (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Immunohistochemistry (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Immunohistochemistry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Immunohistochemistry Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Immunohistochemistry Industry: SWOT Analysis
  • Figure 76: Global: Immunohistochemistry Industry: Value Chain Analysis
  • Figure 77: Global: Immunohistochemistry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohistochemistry Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Immunohistochemistry Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Immunohistochemistry Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Immunohistochemistry Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Immunohistochemistry Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Immunohistochemistry Market: Competitive Structure
  • Table 7: Global: Immunohistochemistry Market: Key Players
目次
Product Code: SR112023A4404

Abstract

The global immunohistochemistry market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.96% during 2022-2028.

Immunohistochemistry (IHC) is a laboratory method for checking specific antigens in a tissue sample using antibodies. The antibodies generally bind to an enzyme or a fluorescent dye, which helps researchers see an antigen under a microscope. IHC is widely used to diagnose chronic diseases like cancer and aids in distinguishing their types. As compared to conventional enzyme staining techniques that identify a limited number of proteins, enzymes, and tissue structures, IHC involves specific antigen-antibody reactions. As a result, it is gaining traction as a crucial technique in medical research laboratories and clinical diagnostics to visualize the distribution and localization of specific cellular components within cells.

Immunohistochemistry Market Trends:

The sudden onset of coronavirus disease (COVID-19) has led to a global healthcare crisis. This is escalating the need for IHC for quick and effective drug development and diagnosis of the infection. Apart from this, significant growth in the number of individuals who have cancer, tumors, muscle diseases, and neurodegenerative disorders acts as another key factor driving the market. Moreover, IHC can characterize various biological processes and pathologies, including wound-healing, immune response, and tissue rejection and biomaterial interactions. As a result, it is gaining traction to determine the function of specific gene products in fundamental biological processes and confirm infectious agents in tissues. Moreover, several novel fluorescent dyes, excellent color contrast, high resolution, and simultaneous multicolor imaging have been introduced recently. These innovations are anticipated to make immunofluorescence microscopy a convenient tool for studying pathobiological processes at the cellular level in the forthcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunohistochemistry market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application, end use.

Breakup by Product:

Antibodies

Primary Antibodies

Secondary Antibodies

Equipment

Slide Staining Systems

Tissue Microarrays

Tissue Processing Systems

Slide Scanners

Others

Reagents

Histological Stains

Blocking sera and Reagents

Chromogenic Substrates

Fixation Reagents

Stabilizers

Organic Solvents

Proteolytic Enzymes

Diluents

Kits

Breakup by Application:

Diagnostics

Cancer

Infectious Diseases

Cardiovascular Diseases

Autoimmune Diseases

Diabetes Mellitus

Nephrological Diseases

Drug Testing

Breakup by End Use:

Hospitals and Diagnostic Laboratories

Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global immunohistochemistry market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global immunohistochemistry market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunohistochemistry market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohistochemistry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Primary Antibodies
      • 6.1.2.2 Secondary Antibodies
    • 6.1.3 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Slide Staining Systems
      • 6.2.2.2 Tissue Microarrays
      • 6.2.2.3 Tissue Processing Systems
      • 6.2.2.4 Slide Scanners
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Reagents
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Histological Stains
      • 6.3.2.2 Blocking sera and Reagents
      • 6.3.2.3 Chromogenic Substrates
      • 6.3.2.4 Fixation Reagents
      • 6.3.2.5 Stabilizers
      • 6.3.2.6 Organic Solvents
      • 6.3.2.7 Proteolytic Enzymes
      • 6.3.2.8 Diluents
    • 6.3.3 Market Forecast
  • 6.4 Kits
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Cancer
      • 7.1.2.2 Infectious Diseases
      • 7.1.2.3 Cardiovascular Diseases
      • 7.1.2.4 Autoimmune Diseases
      • 7.1.2.5 Diabetes Mellitus
      • 7.1.2.6 Nephrological Diseases
    • 7.1.3 Market Forecast
  • 7.2 Drug Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Diagnostic Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio SB Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Bio-Rad Laboratories Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Bio-Techne Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Cell Signaling Technology Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 F. Hoffmann-La Roche AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Merck KGaA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Perkinelmer Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis